. 2018 Jun 13;8:9074. doi: 10.1038/s41598-018-27447-5

Table 1.

Clinical features of the 52 cats with sporotrichosis in the first appointment before treatment with itraconazole (T1) and in the appointment between the 5th and 11th week after the beginning of itraconazole treatment (T2).

Clinical features	Classification	Number of cats (n = 52)		p^b
Clinical features	Classification	T1	T2	p^b
Body condition	Good	37	41	0.344
Body condition	Fair/poor	15	11
Distribution of skin lesions	L1/L2	17	34	<0.001*
Distribution of skin lesions	L3	35	18
Number of skin lesions	≤3	23	48	<0.001*
Number of skin lesions	>3	29	4
Nasal mucosa lesions	Yes	32	32	1.000
Nasal mucosa lesions	No	20	20
Respiratory signs^a	Yes	32	32	1.000
Respiratory signs^a	No	20	20

L1, lesions at one site; L2, lesions at 2 non-contiguous sites; L3, lesions at 3 or more non-contiguous sites; n, total number of cats examined. ^aSneezing, nasal discharge or dyspnoea; ^bMcNemar test. *Significant difference (p < 0.05).